Clinico-economic outcomes of Schwann cell-mediated treatment of diabetes-induced peripheral neurodegenerative disease

This retrospective, longitudinal study evaluated the effectiveness of combining low‐intensity pulsed ultrasound (LIPUS) and extracorporeal shock wave therapy (ESWT) as a non‐invasive treatment for diabetic peripheral neuropathy (DPN). The study analyzed the medical records of 44 patients who completed a 13‐treatment course at a DPN treatment center. Pain severity and functional interference were measured using the modified Brief Pain Inventory for DPN (BPI-DPN), which yielded composite scores for the Pain Severity Index (PSI) and Pain Interference Index (PII). The research addressed nine questions; the first eight evaluated symptom reductions, and the ninth examined the influence of demographic and clinical variables on treatment outcomes. Statistical analyses using paired-sample t-tests demonstrated significant reductions from baseline to post-treatment for PII, worst pain, and interference measures related to sleep, walking ability, and enjoyment of life, while Wilcoxon Signed-Rank tests also confirmed significant reductions for PSI, interference with normal work, and interference with relationships. All paired-sample t-tests were p ≤ .002. Notably, PSI decreased from a mean of 4.19 to 1.88, and PII declined from 4.87 to 3.20. Further analysis with Generalized Estimating Equations (GEE) revealed that age (Wald χ²(2) = 16.31, p = .001) and baseline numbness significantly (Wald χ²(1) = 11.25, p < .001) influenced PII reductions. At the same time, no demographic or clinical factors significantly predicted PSI outcomes. These findings indicate that the combined treatment robustly alleviates pain and enhances functional outcomes consistently across a broad cross-section of DPN patients. The study is significant because DPN is a debilitating condition with limited non-pharmacologic treatment options, and neuropathy-related complications account for a substantial portion of diabetes-related medical costs. The findings also reinforce early theories of nerve regeneration, highlighting the role of mechanical stimulation in activating Schwann cells and promoting peripheral nerve repair. Future research should include randomized controlled trials to compare this treatment with standard-of-care therapy and explore their long-term economic benefits.